Pharmaceutical Usefulness of Biopharmaceutics Classification System: Overview and New Trend |
Youn, Yu-Seok
(College of Pharmacy, Pusan National University)
Lee, Ju-Ho (College of Pharmacy, Pusan National University) Jeong, Seong-Hoon (College of Pharmacy, Pusan National University) Shin, Beom-Soo (College of Pharmacy, Catholic University of Daegu) Park, Eun-Seok (School of Pharmacy, Sungkyunkwan University) |
1 | Zakeri-Milani, P., Valizadeh, H., Tajerzadeh, H., Islambulchilar, Z., 2009b. The utility of rat jejunal permeability for biopharmaceutics classification system. Drug. Dev. Ind. Pharm. 35, 1496-1502. DOI |
2 | Zakeri-Milani, P., Valizadeh, H., Tajerzadeh, H., Islambulchilar, Z., 2009c. The utility of rat jejunal permeability for biopharmaceutics classification system. Drug. Dev. Ind. Pharm. [Epub ahead of print]. |
3 | Taub, M.E., Kristensen, L., Frokjaer, S., 2002. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur. J. Pharm. Sci. 15, 331-340. DOI |
4 | van de Waterbeemd, H., 1998. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. Eur. J. Pharm. Sci. 7, 1-3. DOI |
5 | Wu, C.Y., Benet, L.Z., 2005. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22, 11-23. DOI |
6 | Yu, L.X., Amidon, G.L., Polli, J.E., Zhao, H., Mehta, M.U., Conner, D.P., Shah, V.P., Lesko, L.J., Chen, M.L., Lee, V.H., Hussain, A.S., 2002. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19, 921-925. DOI |
7 | Yu, L.X., Carlin, A.S., Amidon, G.L., Hussain, A.S., 2004. Feasibility studies of utilizingdisk intrinsic dissolution rate to classify drugs. Int. J. Pharm. 270, 221-227. DOI |
8 | Yu, L.X., Carlin, A.S., Amidon, G.L., Hussain, A.S., 2004. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. Int. J. Pharm. 11, 270, 221-227. DOI |
9 | Yu, L.X., Lipka, E., Crison, J.R., Amidon, G.L., 1996. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv. Drug. Deliv. Rev. 19, 359-376. DOI |
10 | Zakeri-Milani, P., Barzegar-Jalali, M., Azimi, M., Valizadeh, H., 2009a. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. Eur. J. Pharm. Biopharm. 73, 102-106. DOI |
11 | Lindenberg, M., Kopp, S., Dressman, J.B., 2004. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur, J. Pharm. Biopharm. 58, 265-278. DOI |
12 | Lobenberg, R., Amidon, G.L., Eur, J., 2000. Modern bioavail-ability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Pharm. Biopharm. 50, 3-12. DOI |
13 | Martinez, M.N., Amidon, G.L., 2002. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J. Clin. Pharmacol. 42, 620-643. DOI |
14 | Papadopoulou, V., Valsami, G., Dokoumetzidis, A., Macheras, P., 2008. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples. Int. J. Pharm. 361, 70-77. DOI |
15 | Rege, B.D., Yu, L.X., Hussain, A.S., Polli, J.E., 2001. Effect of common excipients on Caco-2 transport of low-permeability drugs. J. Pharm. Sci. 90, 1776-1786. DOI ScienceOn |
16 | Shargel, L., Wu-Pong, S., Yu, A., 2004. 5th edition, Chapter 15, Applied biopharmaceutics and pharmacokinetics. |
17 | Sinko, P.J., Leesman, G.D., Amidon, G.L., 1991. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm. Res. 8, 979-988. DOI |
18 | Amidon, G.L., Lennernas, H., Shah, V.P., Crison, J.R., 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413-420. DOI |
19 | Tannergren, C., Knutson, T., Knutson, L., Lennernas, H., 2003. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. Br. J. Clin. Pharmacol. 55, 182-190. DOI |
20 | Tannergren, C., Langguth, P., Hoffmann, K.J., 2001. Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity. Pharmazie. 56, 337-342 |
21 | Avdeef, A., 2001. Physicochemical profiling (solubility, permeability and charge state). Curr. Top. Med. Chem. 1, 277-351. DOI |
22 | Bergstrom, C.A., Strafford, M., Lazorova, L., Avdeef, A., Luthman, K., Artursson, P., 2003. Absorption classification of oral drugs based on molecular surface properties. J. Med. Chem. 46, 558-570. DOI |
23 | Dahlan, R., McDonald, C., Sunderland, V.B., 1987. Solubilities and intrinsic dissolution rates of sulphamethoxazole and trimethoprim. J. Pharm. Pharmacol. 39, 246-251. DOI |
24 | Fleisher, D., Li, C., Zhou, Y., Pao, L.H., Karim, A., 1999. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin. Pharmacokinet. 36, 233-254. DOI |
25 | Food and Drug Administration. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. 2000. Available at http://www.fda.gov/cder/guidance/index. |
26 | Amidon, G.L., Higuchi, W.I., Ho, N.F., 1982. Theoretical and experimental studies of transport of micelle-solubilized solutes. J. Pharm. Sci. 71, 77-84. DOI |
27 | Jinno, J., Oh, D., Crison, J.R., Amidon, G.L., 2000. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J. Pharm. Sci. 89, 268-274. DOI |
28 | Lennernas, H., 1997. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 49, 627-638. DOI ScienceOn |
29 | Lennernas, H., Knutson, L., Knutson, T., Hussain, A., Lesko, L., Salmonson, T., Amidon, G.L., 2002. The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique. Eur. J. Pharm. Sci. 15, 271-277. DOI |
![]() |